Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
Date:2/26/2013

ermination ofPfizer European collaboration

$
93.6$
-$
93.6$
-(2)

includes the following amounts ofstock-based compensation expense:Cost of goods sold

$
.0$
.0$
.1$
.1Research and development

$
.9$
.8$
2.9$
3.2Selling, general and administrative

$
3.0$
4.3$
2.0$
4.0(3)

includes costs recorded as aresult of mutual termination ofPfizer European collaboration

$
8.4$
-$
8.4$
-(4)

includes net income recorded as aresult of mutual termination ofPfizer European collaboration

$
85.2$
-$
85.2$

AUXILIUM PHARMACEUTICALS, INC.Table 2- Selected Consolidated Balance Sheet Data(In millions)(Unaudited)December 31,December 31,20122011Cash and cash equivalents and short term investments$
57.4$
54.3Total assets327.4301.0Total stockholders' equity 199.984.4 

 

AUXILIUM PHARMACEUTICALS, INC.Table 3- 4th Quarter 2012 Revenue Details(In millions, except for percentages)(Unaudited)Three Months Ended December 31,Increase20122011 (Decrease)Testim U.S. Revenue

$58.4$56.93%Testim Ex – U.S. Royalty & Contract Rev.

1.30.779%Total Testim Revenue

59.757.64%XIAFLEX U.S. Revenue

17.513.430%Subtotal

77.271.09%XIAFLEX Royalty & Contract Rev.

95.32.2n/aTotal XIAFLEX Revenue

112.715.7619%Total Worldwide Revenue

$172.5$73.3135%Contract Revenues represent amortization of previously received upfront and milestone payments. 

AUXILIUM PHARMACEUTICALS, INC.Table 4- Full Year 2012 Revenue Details(In millions, except for percentages)(Unaudited)Twelve Months Ended December 31,Increase20122011 (Decrease)Testim U.S. Revenue

$233.4$205.114%Testim Ex – U.S. Royalty & Contract Rev.

4.02.842%Total Testim Revenue

237.5207.914%XIAFLEX U.S. Revenue

55.242.231%XIA
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Auxilium Announces Appointments to Enhance Leadership Team
2. Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
3. Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 Healthcare Conference
4. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
5. Auxilium Pharmaceuticals, Inc. to Present At The Oppenheimer 23rd Annual Growth Conference
6. Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2012 Results and Conduct Conference Call on Tuesday, February 26, 2013
7. Auxilium Pharmaceuticals, Inc. to Present at the Leerink Swann Global Healthcare Conference
8. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
9. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
10. Silence Therapeutics Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silences AtuRNAi in a New Indication
11. MAP Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... VANCOUVER , June 30, 2015 /PRNewswire/ - ... a clinical stage regenerative medicine company focused on ... the first participant in its Phase 1/2 clinical ... of chronic unilateral Achilles tendinosis, has been enrolled ... to intra-tendon ultrasound-guided injections. RCT-01 is comprised of ...
(Date:6/29/2015)... ... , ... This cutting edge standard making is a madatory tool for use ... WAV-8 is the world’s first cuvette-shaped, solid-state filter that lets metrologists and quality control ... spectrophotometer calibration standards, such as those made from didymium glass were only able to ...
(Date:6/29/2015)... WASHINGTON , June 29, 2015  AACC, ... to better health through laboratory medicine, is pleased ... journal, Clinical Chemistry , has increased to ... Reports. This increase places Clinical Chemistry ... and reflects the significant influence of the research ...
(Date:6/29/2015)... Calif. , June 29, 2015   Veracyte, ... company pioneering the field of molecular cytology, today announced ... News Group,s prestigious Top Workplaces list for the second ... Workplace winners based solely on an annual survey of ... and honored that the degree to which Veracyte values ...
Breaking Biology Technology:RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 2FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 3AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 2AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 3Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 2Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 3
... University of Wisconsin-Madison spinoff developing a drug for people with ... $1.6 million, of which it has received the first portion, ... developing drug candidates. , ,Trevor Twose, Mithridion's CEO, said the ... that he may hire six people by the end of ...
... was sent an announcement of pending Illinois broadband legislation ... Here's its synopsis: , Creates the Universal Access to ... Services (CMS) to create and maintain a map of ... publicly held broadband infrastructure shall be available for lease ...
... to a biotech company (it is priority #1, #2, and ... sense) companies are continually faced with the challenge of raising ... article will focus on venture capital financing results for 2005. ... from Burrill and Company's data. Burrill's perspective is more towards ...
Cached Biology Technology:Mithridion raises $1.6M through angel networks 2Proposed Illinois broadband act falls short 2Proposed Illinois broadband act falls short 3Proposed Illinois broadband act falls short 4Proposed Illinois broadband act falls short 5U.S. VC funding flat in 2005 while life science funding grows 2U.S. VC funding flat in 2005 while life science funding grows 3U.S. VC funding flat in 2005 while life science funding grows 4
(Date:6/29/2015)... 2015 Research and Markets( ... "Latin America Biomedical Sensors Market - Growth, Trends & ... The Latin America Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
(Date:6/25/2015)... DALLAS , June 25, 2015 ... report "Fingerprint Sensors Market by Type (Swipe & Area), Technology, ... (Mobile, Government, Healthcare, Commercial Security & Others) & ... published by marketsandmarkets, the said market is expected ... CAGR of 17.1%. Browse 76 ...
(Date:6/25/2015)... 25, 2015  TAKE Solutions Ltd., a global business ... United States Patent and Trademark Office (USPTO) for its ... TAKE Solutions, Clinical Accelerators to reduce the time taken ... to standardization without the accelerators), thus reducing time to ... At the heart of the patented Clinical Data ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4TAKE Solutions Awarded Patent By USPTO 2
... This news release is available in German ... fever, diarrhoea -- these symptoms could point to an infection ... is based on a syringe-like injection apparatus called injectisome. For ... at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, ...
... oligodendrocyte precursor cells (OPC) migrate to the lesion and ... the Institute of Molecular Cell Biology at Johannes Gutenberg ... protein regulates the direction and movement of OPC toward ... at the surface of OPCs and down-regulated as they ...
... Western Reserve University has granted a two-year technology ... a hand-held device that diagnoses malaria more quickly, ... Diagnostic Group LLC, the startup formed last summer ... of Engineering, also raised $250,000 to "field-test" the ...
Cached Biology News:3-D molecular syringes 23-D molecular syringes 3Scientists at Mainz University decode mechanisms of cell orientation in the brain 2CWRU grants Disease Diagnostic Group option on malaria diagnostic device 2
...
... An entire pressurized perfusion system ... in physiology, biophysics, electrochemistry, or general ... as little as 100 microliters of ... eight solutions in milliseconds from a ...
...
Request Info...
Biology Products: